Award

NHS SY ICB - SYB Cancer Alliance - Lung Cancer Screening

NHS SOUTH YORKSHIRE INTEGRATED CARE BOARD

This public procurement record has 1 release in its history.

Award

10 Feb 2026 at 13:12

Summary of the contracting process

The NHS South Yorkshire Integrated Care Board (SY ICB) is set to award a direct contract to Alliance Medical Ltd for the continued provision of Lung Cancer Screening services across South Yorkshire and Bassetlaw. This procurement process, governed by the Health Care Services (Provider Selection Regime) Regulations 2023, bypasses the typical prior call for competition under a limited procurement method. The contract, valued at £4,895,600, will span from 1st April 2026 to 30th September 2028. This decision follows the approval by the NHS SY ICB - Informal Executive Group and enters the Standstill Period with representations due by midnight on 20th February 2026. The services fall under the Medical Analysis Services category, highlighting an ongoing commitment to expanding and integrating the screening programme towards becoming a national initiative.

This contract represents a significant opportunity for businesses within the medical services and healthcare sectors, especially those involved in diagnostics and screening services. By integrating into an existing service structure and leveraging on established patient pathways and operational processes, businesses can contribute to a critical public health initiative aimed at improving early lung cancer detection and reducing health inequalities. Companies with expertise in medical logistics, mobile services, or those capable of offering innovative solutions to enhance service quality and operational efficiency may find this opportunity particularly conducive to growth. Emphasis on integration and sustainable operations suggests alignment with partners already engaged in similar healthcare projects or those seeking entry into established networks can prove advantageous.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NHS SY ICB - SYB Cancer Alliance - Lung Cancer Screening

Notice Description

SY ICB are looking to re-new an existing service which is already commissioned across South Yorkshire and Bassetlaw. The SYB Lung Cancer Screening programme has been operational since March 2021, so has made great strides towards 100% roll out. As an established programme, we are now having to factor in second, third and potentially fourth screening rounds ahead of the transition to becoming a national screening programme (timeline tbc).

Lot Information

Lot 1

SY ICB are looking to re-new an existing service which is already commissioned across South Yorkshire and Bassetlaw. The SYB Lung Cancer Screening programme has been operational since March 2021, so has made great strides towards 100% roll out. As an established programme, we are now having to factor in second, third and potentially fourth screening rounds ahead of the transition to becoming a national screening programme (timeline tbc). Incident scans and nodule surveillance scans beyond 24mths were not a consideration when our services were first commissioned, nor is there much in the way of national guidance to support this, but we have a duty of care to our eligible population to continue screening them every two years while ever they meet the eligibility criteria. This service must be delivered in conjunction with existing services within SY ICB to allow for the best use of resources for SY ICB while ensuring equality of all patients included in the programme both previously and currently.

NHS SY ICB are intending to award a contract an existing provider following Direct Award Process C

The lifetime value of the contract is expected to be PS4,895,600

The dates between which the contract will run from are: 1st April 2026 - 30th Sept 2028


Key Criteria 1 - Quality & Innovation. - Weighting 30%

The purpose of continuing care for all original screening cohorts is to promote health inequalities and demonstrate SY ICB's commitment to deliver on national guidance to ensure all those eligible are receiving lung health checks. The provider must be able to fit into and extend the current commissioned services to ensure best use of resources by filling current scanner appointments, while ensuring original cohorts are invited to attend in line with these already established locations and processes.

Key Criteria 2. - Weighting 30%

SY ICB are aiming to ensure that the commissioning of continued care in the form of regular incident scans, is done in the most cost-effective manner, enabling the best use of resources for the organisation.
In order to achieve this SY ICB are looking to commission this service to merge with existing resources to reduce the financial and resourcing impact while enabling us to maintain the offer of LCS to all who are eligible on a rolling basis. It is imperative that this service is provided by an existing provider in this space to avoid the need for duplication of resources and thus cost to SY ICB while ensuring that all patients undertaking a LCS are treated the same and placed on the already established pathways.

Key criteria 3 - Integration, collaboration and service sustainability - Weighting 10%

Our decision to extend this service is influenced by the NHSE Standard Protocol for LCS which states: '..repeat scan every 2 years until no longer eligible by age or other exclusion criteria'. As an organisation we remain committed to upholding this obligation, given that these patients have already been assessed as high risk of developing lung disease including lung cancer and their risk will only increase with age. Screening provides the best chance of finding the disease early. This ambition is reflected within the NHS Long Term Plan to diagnose 3 out of 4 people with cancer at the early stage by 2028.
Using the current service would improve the sustainability of the new service by allowing operational flexibility, patient flexibility and minimising time and operational costs for the provider to ensure the best value and service for patients.

See section II.2.14.1 - Additional information for the remaining Key Criteria. Additional information: Key criteria 4 - Improving access, reducing health inequalities and facilitating choice - Weighting 20%

While the initial rollout of SY ICB's LCS programme was planned to target, cover and provide for those experiencing greater health inequalities while promoting choice and access, its been recognised that this can be expanded further in the five years the programme has been running. As an organisation we were aware via the Standard Protocol of our obligation to ensure all participants receive at least two LDCT screening round scans (baseline or 24 month scan) before exiting the programme, but we hadn't factored into trajectories or contracts, those patients who might qualify for more then two LDCT screening rounds and now better understand the quantity of these patients. We have now refined accessibility to the service through working with the current provider and their sub-contractors which allows us to target the specific cohorts in question to reduce non-attendance.

Key criteria 5 - Social Value - Weighing 10%

The purpose of this project is wholly based on improving patients access to care, early diagnosis and reducing health inequalities. Specifically, this extension to the LCS programme will further ensure equal opportunity is met as we seek to proactively diagnose early-stage cancer in all patients in a mobile setting. This early diagnosis outcome will also result in a general improvement for wellbeing for those effected as they will either be placed on the appropriate pathway for the care they need or advised of a nil finding despite being eligible due to the risk factors. As this service is mobile in nature and commissioned on a basis in which the existing provider will attend multiple sites at different times this will allow patients to attend appointments that most suit their location, reducing their travel time and increasing uptake by offering them convenience.

Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by midnight on 20/02/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-064c81
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/011865-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85148000 - Medical analysis services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£4,895,600 £1M-£10M

Notice Dates

Publication Date
10 Feb 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
5 Feb 20262 weeks ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS SOUTH YORKSHIRE INTEGRATED CARE BOARD
Contact Name
Procurement department
Contact Email
syicb.procurement@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
SHEFFIELD
Postcode
S1 3FG
Post Town
Sheffield
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE3 South Yorkshire
Small Region (ITL 3)
TLE32 Sheffield
Delivery Location
TLE3 South Yorkshire

Local Authority
Sheffield
Electoral Ward
City
Westminster Constituency
Sheffield Central

Supplier Information

Number of Suppliers
1
Supplier Name

ALLIANCE MEDICAL

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-064c81-2026-02-10T13:12:22Z",
    "date": "2026-02-10T13:12:22Z",
    "ocid": "ocds-h6vhtk-064c81",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2024 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by midnight on 20/02/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>Written representation should be may, via email to - syicb-sheffield.syicb.procurement@nhs.net<br/><br/>The award of this contract has been approved by the NHS SY ICB - Informal Executive Group during a meeting on 05/02/2026.<br/><br/>No conflicts of interest were declared.<br/><br/>Please see sections II.2.4.1 & II.2.14.1 for details of key criteria that the relevant authority used to make a decision, the rationale for the relative importance of the key criteria, and the rationale for choosing the provider with reference to the key criteria.",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-064c81",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NHS SY ICB - SYB Cancer Alliance - Lung Cancer Screening",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85148000",
            "description": "Medical analysis services"
        },
        "mainProcurementCategory": "services",
        "description": "SY ICB are looking to re-new an existing service which is already commissioned across South Yorkshire and Bassetlaw. The SYB Lung Cancer Screening programme has been operational since March 2021, so has made great strides towards 100% roll out. As an established programme, we are now having to factor in second, third and potentially fourth screening rounds ahead of the transition to becoming a national screening programme (timeline tbc).",
        "lots": [
            {
                "id": "1",
                "description": "SY ICB are looking to re-new an existing service which is already commissioned across South Yorkshire and Bassetlaw. The SYB Lung Cancer Screening programme has been operational since March 2021, so has made great strides towards 100% roll out. As an established programme, we are now having to factor in second, third and potentially fourth screening rounds ahead of the transition to becoming a national screening programme (timeline tbc). Incident scans and nodule surveillance scans beyond 24mths were not a consideration when our services were first commissioned, nor is there much in the way of national guidance to support this, but we have a duty of care to our eligible population to continue screening them every two years while ever they meet the eligibility criteria. This service must be delivered in conjunction with existing services within SY ICB to allow for the best use of resources for SY ICB while ensuring equality of all patients included in the programme both previously and currently. <br/><br/>NHS SY ICB are intending to award a contract an existing provider following Direct Award Process C <br/><br/>The lifetime value of the contract is expected to be PS4,895,600<br/><br/>The dates between which the contract will run from are: 1st April 2026 - 30th Sept 2028 <br/><br/><br/>Key Criteria 1 - Quality & Innovation. - Weighting 30%<br/><br/>The purpose of continuing care for all original screening cohorts is to promote health inequalities and demonstrate SY ICB's commitment to deliver on national guidance to ensure all those eligible are receiving lung health checks. The provider must be able to fit into and extend the current commissioned services to ensure best use of resources by filling current scanner appointments, while ensuring original cohorts are invited to attend in line with these already established locations and processes. <br/><br/>Key Criteria 2. - Weighting 30%<br/><br/>SY ICB are aiming to ensure that the commissioning of continued care in the form of regular incident scans, is done in the most cost-effective manner, enabling the best use of resources for the organisation. <br/>In order to achieve this SY ICB are looking to commission this service to merge with existing resources to reduce the financial and resourcing impact while enabling us to maintain the offer of LCS to all who are eligible on a rolling basis. It is imperative that this service is provided by an existing provider in this space to avoid the need for duplication of resources and thus cost to SY ICB while ensuring that all patients undertaking a LCS are treated the same and placed on the already established pathways. <br/><br/>Key criteria 3 - Integration, collaboration and service sustainability - Weighting 10%<br/><br/>Our decision to extend this service is influenced by the NHSE Standard Protocol for LCS which states: '..repeat scan every 2 years until no longer eligible by age or other exclusion criteria'. As an organisation we remain committed to upholding this obligation, given that these patients have already been assessed as high risk of developing lung disease including lung cancer and their risk will only increase with age. Screening provides the best chance of finding the disease early. This ambition is reflected within the NHS Long Term Plan to diagnose 3 out of 4 people with cancer at the early stage by 2028.<br/>Using the current service would improve the sustainability of the new service by allowing operational flexibility, patient flexibility and minimising time and operational costs for the provider to ensure the best value and service for patients.<br/><br/>See section II.2.14.1 - Additional information for the remaining Key Criteria. Additional information: Key criteria 4 - Improving access, reducing health inequalities and facilitating choice - Weighting 20%<br/><br/>While the initial rollout of SY ICB's LCS programme was planned to target, cover and provide for those experiencing greater health inequalities while promoting choice and access, its been recognised that this can be expanded further in the five years the programme has been running. As an organisation we were aware via the Standard Protocol of our obligation to ensure all participants receive at least two LDCT screening round scans (baseline or 24 month scan) before exiting the programme, but we hadn't factored into trajectories or contracts, those patients who might qualify for more then two LDCT screening rounds and now better understand the quantity of these patients. We have now refined accessibility to the service through working with the current provider and their sub-contractors which allows us to target the specific cohorts in question to reduce non-attendance.<br/><br/>Key criteria 5 - Social Value - Weighing 10%<br/><br/>The purpose of this project is wholly based on improving patients access to care, early diagnosis and reducing health inequalities. Specifically, this extension to the LCS programme will further ensure equal opportunity is met as we seek to proactively diagnose early-stage cancer in all patients in a mobile setting. This early diagnosis outcome will also result in a general improvement for wellbeing for those effected as they will either be placed on the appropriate pathway for the care they need or advised of a nil finding despite being eligible due to the risk factors. As this service is mobile in nature and commissioned on a basis in which the existing provider will attend multiple sites at different times this will allow patients to attend appointments that most suit their location, reducing their travel time and increasing uptake by offering them convenience.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "name": "Cost",
                            "type": "cost",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKE3"
                    }
                ],
                "deliveryLocation": {
                    "description": "South Yorkshire"
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by midnight on 20/02/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'."
    },
    "awards": [
        {
            "id": "011865-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-174022",
                    "name": "Alliance Medical Ltd"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-113634",
            "name": "NHS South Yorkshire Integrated Care Board",
            "identifier": {
                "legalName": "NHS South Yorkshire Integrated Care Board"
            },
            "address": {
                "streetAddress": "197 Eyre Street",
                "locality": "Sheffield",
                "region": "UKE32",
                "postalCode": "S1 3FG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Procurement department",
                "email": "syicb.procurement@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.southyorkshire.icb.nhs.uk/",
                "buyerProfile": "https://www.southyorkshire.icb.nhs.uk/",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-174022",
            "name": "Alliance Medical Ltd",
            "identifier": {
                "legalName": "Alliance Medical Ltd"
            },
            "address": {
                "locality": "Warwick",
                "region": "UK",
                "postalCode": "CV34 5AH",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-130973",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Wellington House, 133-135 Waterloo Rd",
                "locality": "London",
                "postalCode": "SE1 8UG",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "england.commercialqueries@nhs.net"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-113634",
        "name": "NHS South Yorkshire Integrated Care Board"
    },
    "contracts": [
        {
            "id": "011865-2026-1",
            "awardID": "011865-2026-1",
            "status": "active",
            "value": {
                "amount": 4895600,
                "currency": "GBP"
            },
            "dateSigned": "2026-02-05T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}